Skip to main content
Access every election story that matters
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Access every election story that matters
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
// //

The U.S. Food and Drug Administration (FDA) is investigating how a cancer-causing chemical ended up in Johnson & Johnson sunscreens, after the company said it had done internal testing and found low levels of benzene in some, the regulator said on Friday.

J&J, which issued a voluntarily recall of the five different Neutrogena and Aveeno brand products, began testing after Valisure – an online pharmacy that tests its products for contaminants – found benzene in dozens of suncare products and asked the FDA to look into it in May.

“The root cause of the benzene found in recalled sunscreen products is the focus of ongoing investigation,” FDA spokesman Jeremy Kahn said. “We will continue to monitor sunscreen manufacturing and marketing to help ensure the availability of safe sunscreens for U.S. consumers.”

Story continues below advertisement

On Friday, Valisure Chief Executive David Light said in an interview that he believes the benzene will likely be traced to contaminated raw materials and that he does not believe that the problem is inherent to aerosol sunscreens, or sunscreens in general.

“There’s probably the most evidence for raw material contamination,” Light said. He said that is because the contamination was found in a scattered fashion among brands, and even within brands, suggesting that it was unlikely to be a problem with the chemical or mineral active ingredients.

Valisure also found benzene in products made by other companies than J&J. CVS has halted sales of two of its sunburn healing products, which were in Valisure’s petition.

The market for suncare products was around $8 billion globally last year, and J&J sold around $620 million of its brands. In the U.S., the market was around $1.6 billion and J&J’s sales were around $290 million, according to EuroMonitor. Shares were flat on Friday at $168.12.

Benzene is a chemical frequently used in manufacturing processes to make other chemicals, said Dr. Adam Friedman, a professor and chair of dermatology at George Washington University School of Medicine. He said benzene is not a byproduct of sunscreen filters – the various minerals or chemicals used to block the sun’s harmful rays.

Dr. Joe Schwarcz, a chemistry professor and director of the Office for Science and Society at McGill University in Montreal said in an e-mail that he believed “the risk is minimal because the dose of benzene is too small.”

The FDA said that given the recognized public health benefits of sunscreen, parents should continue to use broad spectrum sunscreens with SPF 15 or higher.

Story continues below advertisement

Friedman said several summer camps are collecting all forms of aerosol sun block, not just J&J, including Camp Tawanda in Honsedale, Pennsylvania, his children’s sleep away camp, where Friedman is volunteering as camp doctor.

“I have a trunk full of sunscreens for everybody,” he said.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies